BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8823270)

  • 1. First experiences with superfractionated skin irradiations using large afterloading molds.
    Fritz P; Hensley FW; Berns C; Schraube P; Wannenmacher M
    Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):147-57. PubMed ID: 8823270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of pulsed irradiation of skin metastases from breast cancer. Effectiveness and sequelae.
    Fritz P; Hensley FW; Berns C; Harms W; Wannenmacher M
    Strahlenther Onkol; 2000 Aug; 176(8):368-76. PubMed ID: 10987020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of chest wall reirradiation using pulsed-dose-rate (PDR) brachytherapy molds for breast cancer local recurrences.
    Harms W; Krempien R; Hensley FW; Berns C; Wannenmacher M; Fritz P
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):205-10. PubMed ID: 11163516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDR brachytherapy with flexible implants for interstitial boost after breast-conserving surgery and external beam radiation therapy.
    Fritz P; Berns C; Anton HW; Hensley F; Assman J; Flentje M; von Fournier D; Wannenmacher M
    Radiother Oncol; 1997 Oct; 45(1):23-32. PubMed ID: 9364628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences of optimization in PDR brachytherapy--is a routine geometrical optimization recommendable?
    Berns C; Fritz P; Hensley FW; Wannenmacher M
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1171-80. PubMed ID: 9169828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
    Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
    Perera F; Chisela F; Stitt L; Engel J; Venkatesan V
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1283-90. PubMed ID: 16029783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of the source-skin distance measuring bridge indeed reduces skin teleangiectasia after interstitial boost in breast conserving therapy.
    Georg P; Georg D; Van Limbergen E
    Radiother Oncol; 2005 Mar; 74(3):323-30. PubMed ID: 15763314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
    Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer.
    Harms W; Krempien R; Hensley FW; Berns C; Fritz P; Wannenmacher M
    Strahlenther Onkol; 2002 Nov; 178(11):607-14. PubMed ID: 12426671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial.
    Niehoff P; Polgár C; Ostertag H; Major T; Sulyok Z; Kimmig B; Kovács G
    Radiother Oncol; 2006 Jun; 79(3):316-20. PubMed ID: 16780977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region.
    Richards GM; Tomé WA; Robins HI; Stewart JA; Welsh JS; Mahler PA; Howard SP
    Breast Cancer Res Treat; 2009 Mar; 114(2):307-13. PubMed ID: 18389365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An afterloading 192Ir surface mold.
    Rustgi SN; Cumberlin RL
    Med Dosim; 1993; 18(1):39-42. PubMed ID: 8507359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT computer-optimized high-dose-rate brachytherapy with surface applicator technique for scar boost radiation after breast reconstruction surgery.
    Stewart AJ; O'Farrell DA; Bellon JR; Hansen JL; Duggan C; Czerminska MA; Cormack RA; Devlin PM
    Brachytherapy; 2005; 4(3):224-9. PubMed ID: 16182223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locally recurrent breast cancer: pulse dose rate brachytherapy for repeat irradiation following lumpectomy-- a second chance to preserve the breast.
    Resch A; Fellner C; Mock U; Handl-Zeller L; Biber E; Seitz W; Pötter R
    Radiology; 2002 Dec; 225(3):713-8. PubMed ID: 12461250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer.
    Wazer DE; Berle L; Graham R; Chung M; Rothschild J; Graves T; Cady B; Ulin K; Ruthazer R; DiPetrillo TA
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):889-97. PubMed ID: 12095554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low-risk breast cancer.
    Niehoff P; Ballardini B; Polgár C; Major T; Hammer J; Richetti A; Kovács G
    Breast; 2006 Jun; 15(3):319-25. PubMed ID: 16765284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daytime pulsed dose rate brachytherapy as a new treatment option for previously irradiated patients with recurrent oesophageal cancer.
    Harms W; Krempien R; Grehn C; Berns C; Hensley FW; Debus J
    Br J Radiol; 2005 Mar; 78(927):236-41. PubMed ID: 15730988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative brachytherapy for pretreated chest wall recurrence of breast cancer.
    Mayer A; Naszály A; Patyánik M; Zaránd P; Polgár I; Klinkó T
    Strahlenther Onkol; 2002 Nov; 178(11):633-6. PubMed ID: 12426674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and tolerance of pulsed dose rate interstitial brachytherapy.
    de Pree C; Popowski Y; Weber D; Nouet P; Rouzaud M; Kurtz JM
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):971-6. PubMed ID: 10192342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.